Methods and compositions for diagnosing and treating chromosome-18p related disorders
CA 2323830 A1 · Owner: The Regents Of The University Of California · Inventors: Chen, Hong; Freimer, Nelson B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the mammalian HKNG1 gene a gene associated , with bipolar affective disorder (BAD) in humans. The invention relates in , particular, to methods for the diagnostic evaluation genetic testing and , prognosis of HKNG1 neuropsychiatric disorders including schizophrenia attention deficit disorder, a schizoaffective disorder a bipolar affective , disorder or a unipolar affective disorder.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 16, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 16, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 16, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.